Pharmaceutical giant Pfizer has lost the sole right to manufacture Viagra UK in Brazil after judges decided the market for the drug should be opened up.
The country's Supreme Federal Court voted 5-1 in favour of overturning an earlier lower court ruling that gave the firm exclusivity until June 2011.
The decision, which paves the way for a raft of generic versions of the erectile dysfunction treatment, was made after Brazil's National Institute of Industrial Property said the patent should be allowed to expire on June 20.
Pfizer, which may yet appeal the ruling, argued it had been given a 10-year patent by the European Commission in June 1991.
Around 7.1 million doses of the blue pill, which works by increasing blood flow, have been sold in the country since 2007.
Viagra is one of the most popular drugs in the world.
Medical Specialist® are a registered UK pharmacy established in 1994 providing prescription & non prescription medication online since 2001.
Thursday, 29 April 2010
Wednesday, 28 April 2010
A New York restaurant serves up "Viagra Soup"
A Spanish chain of restaurants in Brooklyn Queens NYC is serving up a special soup to customers which they have dubbed "Viagra Soup"
The seafood-packed stew is supposed to put customers of El Rey Restaurant I, II and III in a loving mood - without a pricey prescription.
"We named it Viagra soup because of the ingredients it has to make you feel stronger, energetic ...and ready when the right time comes along," said Euclides (Junior) Genao, manager of El Rey Restaurant II in Brooklyn. "There's something in seafood that makes you horny."
The sexy stew is chock-full of fish, shrimp, lobster, crabs, clams and half a shot of tequila, Genao said. It is available only by special order and doesn't contain any little blue pills.
The hot soup sells for a whopping $32 a pop - a bit more per pil of Viagra UK advertised online for $79 in the USA.
The seafood-packed stew is supposed to put customers of El Rey Restaurant I, II and III in a loving mood - without a pricey prescription.
"We named it Viagra soup because of the ingredients it has to make you feel stronger, energetic ...and ready when the right time comes along," said Euclides (Junior) Genao, manager of El Rey Restaurant II in Brooklyn. "There's something in seafood that makes you horny."
The sexy stew is chock-full of fish, shrimp, lobster, crabs, clams and half a shot of tequila, Genao said. It is available only by special order and doesn't contain any little blue pills.
The hot soup sells for a whopping $32 a pop - a bit more per pil of Viagra UK advertised online for $79 in the USA.
Friday, 23 April 2010
brits are living longer & longer
one in eight people who turn 50 this year will see the ripe old age of 100 according to a survey found yesterday.
That means the number of Britain’s who live live to see 100 will soar past 300,000 by 2060
Analysts say the booming number of the very elderly is because of advances in medical treatments and a change in the attitudes and lifestyles of the over-50s.
A survey conducted by Saga found that 76 per cent of over-50s are giving themselves a better chance of reaching 100 by being healthier than they have ever been before
Forty-six per cent said they were taking more exercise, 19 per cent said they had climbed a mountain recently and 23 per cent said they had run at least a mile while in their 50s.
One in seven entrants in this weekend’s London Marathon is over 50.
Six in ten over-50s play brain-training computer games and one in eight men over 50 claim to have taken Viagra UK in the past five years.
Only 15 per cent of those of over 50 smoke cigarettes – compared to 40 per cent in the 1970s – and they are four times more likely to take health supplements.
They are six times more likely to be on a low-fat or low cholesterol diet, with 78 per cent saying they are eating a healthier diet.
That means the number of Britain’s who live live to see 100 will soar past 300,000 by 2060
Analysts say the booming number of the very elderly is because of advances in medical treatments and a change in the attitudes and lifestyles of the over-50s.
A survey conducted by Saga found that 76 per cent of over-50s are giving themselves a better chance of reaching 100 by being healthier than they have ever been before
Forty-six per cent said they were taking more exercise, 19 per cent said they had climbed a mountain recently and 23 per cent said they had run at least a mile while in their 50s.
One in seven entrants in this weekend’s London Marathon is over 50.
Six in ten over-50s play brain-training computer games and one in eight men over 50 claim to have taken Viagra UK in the past five years.
Only 15 per cent of those of over 50 smoke cigarettes – compared to 40 per cent in the 1970s – and they are four times more likely to take health supplements.
They are six times more likely to be on a low-fat or low cholesterol diet, with 78 per cent saying they are eating a healthier diet.
Monday, 19 April 2010
Viagra UK
Viagra was founded over ten years ago now and originally was used for studied for high blood pressure & angina.
It was later found after many studies and clinics trials that one of the side effect included getting an erection. This was then explored and Viagra was born.
Viagra UK is probably the most prescribed drug in the world for men.
It was later found after many studies and clinics trials that one of the side effect included getting an erection. This was then explored and Viagra was born.
Viagra UK is probably the most prescribed drug in the world for men.
Do statins lower male sex drive?
An Italian study of men being treated for erectile dysfunction finds an association between the use of cholesterol-lowering statins and abnormally low levels of the male hormone testosterone.
The study “sends a signal worthy of observation,” said Dr. Irwin Goldstein, director of sexual medicine at Alvarado Hospital in San Diego and editor of the Journal of Sexual Medicine. The report is published in the April issue of the journal.
Goldstein noted that, in his practice, he sees patients “several times a week” who say that their sexual performance declined after they started taking a statin.
But an American epidemiologist who did a similar study said the Italian results could be interpreted as saying that statin use reduces the incidence of erectile dysfunction.
That study, of men in Olmsted County, Minn., found a low incidence of impotence in men taking the drugs, with longer use associated with lower incidence. Men who took statins for nine years were 64 percent less likely to develop erectile dysfunction in that study than those who didn’t, said study co-author Jennifer St. Sauver, an epidemiologist at the Mayo Clinic.
The apparently contradictory results could be explained by the different populations in the two studies, St. Sauver said. The Minnesota study included men in the general population, while the Italian study looked only at men being treated for erectile dysfunction.
Thirty percent of the Minnesota men were taking statins. Only 7 percent of the 3,484 men in the Italian study were taking the drugs. The U.S. Centers for Disease Control and Prevention has reported that about 16 percent of U.S. adults use statins. The lower percentage in the Italian study could indicate that statins reduce the need to seek treatment for erectile dysfunction, St. Sauver said.
The Italian study also didn’t have a control group of men without sexual problems, she said, so to establish any cause-effect relationship “you would have to take a group of men without erectile dysfunction and see how many are taking statins,” St. Sauver said.
Men who take statins and have sexual problems shouldn’t stop taking the drug, Goldstein said. “They should see a doctor for a blood test,” he said. “If testosterone is low, they should not stop taking statins but should start testosterone treatment.”
The Italian study is important because “it is the first to bring up this message in a large number of men,” Goldstein added.
One U.S. study, reported in 2007 by the New England Research Institutes, did find lower levels of testosterone in a general population of men taking statins. But detailed analysis of the data found that the reduced levels could be explained by other factors, such as obesity and diabetes, rather than statin use.
That study was done because of reports that statins might lower the risk of prostate cancer by reducing testosterone levels. No such protective effect was found.
Several scattered studies have found a relationship between statin use and lower levels of male hormones. But definitive evidence about such a relationship would require a carefully controlled study, Goldstein said.
The study “sends a signal worthy of observation,” said Dr. Irwin Goldstein, director of sexual medicine at Alvarado Hospital in San Diego and editor of the Journal of Sexual Medicine. The report is published in the April issue of the journal.
Goldstein noted that, in his practice, he sees patients “several times a week” who say that their sexual performance declined after they started taking a statin.
But an American epidemiologist who did a similar study said the Italian results could be interpreted as saying that statin use reduces the incidence of erectile dysfunction.
That study, of men in Olmsted County, Minn., found a low incidence of impotence in men taking the drugs, with longer use associated with lower incidence. Men who took statins for nine years were 64 percent less likely to develop erectile dysfunction in that study than those who didn’t, said study co-author Jennifer St. Sauver, an epidemiologist at the Mayo Clinic.
The apparently contradictory results could be explained by the different populations in the two studies, St. Sauver said. The Minnesota study included men in the general population, while the Italian study looked only at men being treated for erectile dysfunction.
Thirty percent of the Minnesota men were taking statins. Only 7 percent of the 3,484 men in the Italian study were taking the drugs. The U.S. Centers for Disease Control and Prevention has reported that about 16 percent of U.S. adults use statins. The lower percentage in the Italian study could indicate that statins reduce the need to seek treatment for erectile dysfunction, St. Sauver said.
The Italian study also didn’t have a control group of men without sexual problems, she said, so to establish any cause-effect relationship “you would have to take a group of men without erectile dysfunction and see how many are taking statins,” St. Sauver said.
Men who take statins and have sexual problems shouldn’t stop taking the drug, Goldstein said. “They should see a doctor for a blood test,” he said. “If testosterone is low, they should not stop taking statins but should start testosterone treatment.”
The Italian study is important because “it is the first to bring up this message in a large number of men,” Goldstein added.
One U.S. study, reported in 2007 by the New England Research Institutes, did find lower levels of testosterone in a general population of men taking statins. But detailed analysis of the data found that the reduced levels could be explained by other factors, such as obesity and diabetes, rather than statin use.
That study was done because of reports that statins might lower the risk of prostate cancer by reducing testosterone levels. No such protective effect was found.
Several scattered studies have found a relationship between statin use and lower levels of male hormones. But definitive evidence about such a relationship would require a carefully controlled study, Goldstein said.
Thursday, 15 April 2010
Conservative Minister Takes 'herbal Viagra' Live On A TV Show
A conservative MP who appeared on the TV show “The Wright Stuff” was seen taking a “herbal Viagra” tablet live on air during day time TV. Mr Ed Vaizey the Shadow Arts Minister said that he had felt nervous at the time, but once he had taken the tablet he felt some tingling in his hands.
Viapro, the herbal erectile dysfunction treatment, is designed to boost sexual performance. It retails at around £30 and has been dubbed by a number of health experts as the ‘herbal Viagra’. The effects are said to last up to 24 hours. Although no clinical trial have been proven for this medication to work or to be safe.
Matthew Wright presenter of the “The Wright Stuff” also took one of the orange pills. When quizzed on the effects, Vaizey told reporters “it’s quite weird actually’.
Viapro, the herbal erectile dysfunction treatment, is designed to boost sexual performance. It retails at around £30 and has been dubbed by a number of health experts as the ‘herbal Viagra’. The effects are said to last up to 24 hours. Although no clinical trial have been proven for this medication to work or to be safe.
Matthew Wright presenter of the “The Wright Stuff” also took one of the orange pills. When quizzed on the effects, Vaizey told reporters “it’s quite weird actually’.
Wednesday, 14 April 2010
Female Viagra will help women increase their sexual arousal
A female equivalent of Viagra could soon be available to help women increase their sexual arousal, scientists claim.
For years they have endeavoured to create an alternative for women that mimics the effects of the male Viagra pill.
Now, the pharmaceutical company behind the original pill has created a prototype which increases blood flow to the genitalia in a similar way to Viagra
More than half of women experience sexual dysfunction at some point in their lives.
They may suffer a lack of desire, emotional or mental health problems and physical problems that mean they avoid having sex.
Pharmaceutical giant Pfizer has developed a drug, so far called only UK-414,495, which is supposed to increase sexual arousal, but will not affect desire, mood or emotional problems.
Some women take Viagra with mixed results and the drug has been used in fertility treatment to increase blood flow to the pelvis and encourage an embryo to implant in the womb.
But this is the first pill that claims to be an equivalent of the male Viagra.
The research, which involved animals, is published by the British Journal of Pharmacology, though Pfizer say they won’t develop the drug and warn that the chemical may not work the same way in humans, according to the Telegraph.
Chris Wayman, the lead researcher, said: ‘Before this work, we knew surprisingly little about the processes that control all of these changes.
Now that we are beginning to establish the pathways involved in sexual arousal, scientists may be able to find ways of helping women who would like to overcome female sexual arousal disorder.
‘While the particular chemical compound in this research did not prove appropriate for further developments, the implications of the research could lead to the development of a product in the future.’
Viagra was originally developed as a treatment for high blood pressure and the heart condition angina, but men who took part in early trials realised the drug had an interesting side effect.
Clinical trials suggested the drug had little effect on angina and instead induced erections in men.
The drug first went on sale in 1998 and has since been prescribed to 25million men, creating a multi-billion pound global market.
The name Viagra has become so associated with men’s erectile dysfunction problems that many cures are marketed as ‘herbal viagra’.
It is known by many nicknames, including Vitamin V and the Blue Pill.
Please visit for further erectile dysfunction information
Source: Dailymail news paper.
For years they have endeavoured to create an alternative for women that mimics the effects of the male Viagra pill.
Now, the pharmaceutical company behind the original pill has created a prototype which increases blood flow to the genitalia in a similar way to Viagra
More than half of women experience sexual dysfunction at some point in their lives.
They may suffer a lack of desire, emotional or mental health problems and physical problems that mean they avoid having sex.
Pharmaceutical giant Pfizer has developed a drug, so far called only UK-414,495, which is supposed to increase sexual arousal, but will not affect desire, mood or emotional problems.
Some women take Viagra with mixed results and the drug has been used in fertility treatment to increase blood flow to the pelvis and encourage an embryo to implant in the womb.
But this is the first pill that claims to be an equivalent of the male Viagra.
The research, which involved animals, is published by the British Journal of Pharmacology, though Pfizer say they won’t develop the drug and warn that the chemical may not work the same way in humans, according to the Telegraph.
Chris Wayman, the lead researcher, said: ‘Before this work, we knew surprisingly little about the processes that control all of these changes.
Now that we are beginning to establish the pathways involved in sexual arousal, scientists may be able to find ways of helping women who would like to overcome female sexual arousal disorder.
‘While the particular chemical compound in this research did not prove appropriate for further developments, the implications of the research could lead to the development of a product in the future.’
Viagra was originally developed as a treatment for high blood pressure and the heart condition angina, but men who took part in early trials realised the drug had an interesting side effect.
Clinical trials suggested the drug had little effect on angina and instead induced erections in men.
The drug first went on sale in 1998 and has since been prescribed to 25million men, creating a multi-billion pound global market.
The name Viagra has become so associated with men’s erectile dysfunction problems that many cures are marketed as ‘herbal viagra’.
It is known by many nicknames, including Vitamin V and the Blue Pill.
Please visit for further erectile dysfunction information
Source: Dailymail news paper.
Friday, 9 April 2010
life of child saved by viagra
A baby who was born with a large hole in her diaphragm is being kept alive with VIAGRA.
Little Sharice Dunnon nearly died after sucking her stomach into her LUNGS as she drew her first breath.
Shocked parents William Dunnon, 31, and Annmarie Massey, 22, of Kilmarnock, were told just two hours after the tot was born that she had a 50-50 chance of surviving.
Now eight months on and after lifesaving surgery, Sharice is eating normally – thanks to the male erectile dysfunction pill which regulates her heart.
Little Sharice Dunnon nearly died after sucking her stomach into her LUNGS as she drew her first breath.
Shocked parents William Dunnon, 31, and Annmarie Massey, 22, of Kilmarnock, were told just two hours after the tot was born that she had a 50-50 chance of surviving.
Now eight months on and after lifesaving surgery, Sharice is eating normally – thanks to the male erectile dysfunction pill which regulates her heart.
Thursday, 1 April 2010
Pfizer to Sue Teva Over Generic illegal Viagra
Pfizer has sued generic drug-maker Teva Pharmaceuticals Industries LTD in a federal court to halt a generic version of the company’s erectile-dysfunction drug, Viagra, from being sold domestically until 2019, according to reports.
The pharmaceutical behemoth opposes the U.S. Food and Drug Administration’s approval to allow sale of the generic drug by Teva upon expiration of Pfizer’s primary patent in March of 2012 according to The Wall Street Journal.
Viagra is also protected by a patent covering the drug’s use for erectile dysfunction which doesn’t expire until October of 2019; however, Teva, which notified Pfizer of its intent to sell the generic in 2004, claims the 2019 patent “is invalid and/0r will not be infringed” upon by its generic, the paper said.
Shares of Pfizer fell 11 cents or 0.64% in Wednesday’s trading, closing at $17.15 a share
The pharmaceutical behemoth opposes the U.S. Food and Drug Administration’s approval to allow sale of the generic drug by Teva upon expiration of Pfizer’s primary patent in March of 2012 according to The Wall Street Journal.
Viagra is also protected by a patent covering the drug’s use for erectile dysfunction which doesn’t expire until October of 2019; however, Teva, which notified Pfizer of its intent to sell the generic in 2004, claims the 2019 patent “is invalid and/0r will not be infringed” upon by its generic, the paper said.
Shares of Pfizer fell 11 cents or 0.64% in Wednesday’s trading, closing at $17.15 a share
Subscribe to:
Posts (Atom)